Literature DB >> 21303248

Overview of HIV among injection drug users in New York City: critical next steps to eliminate racial/ethnic disparities.

Silvia Amesty1, Alexis V Rivera, Crystal M Fuller.   

Abstract

At the start of the HIV epidemic, 50% of new infections were among injection drug users (IDUs) in New York City. While HIV has declined among IDUs since the mid-1990s, parenteral transmission continues to overburden Blacks/Hispanic IDUs. Individual risk behaviors do not explain the distribution of HIV/AIDS among IDUs. Social and/or structural factors are likely fueling racial disparities creating a high-risk socioenvironmental context. While increased access to structural interventions (i.e., syringe exchange and pharmacy syringe access) is needed, it may not be sufficient to eliminate HIV/AIDS disparities among IDUs. Research on incorporating structural factors into intervention strategies is needed.

Entities:  

Mesh:

Year:  2011        PMID: 21303248      PMCID: PMC3666177          DOI: 10.3109/10826084.2011.523287

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  64 in total

1.  Identifying adolescents at risk for hard drug use: racial/ethnic variations.

Authors:  P L Ellickson; S C Morton
Journal:  J Adolesc Health       Date:  1999-12       Impact factor: 5.012

2.  HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.

Authors:  D C Des Jarlais; M Marmor; P Friedmann; S Titus; E Aviles; S Deren; L Torian; D Glebatis; C Murrill; E Monterroso; S R Friedman
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

3.  Drug use, AIDS knowledge, and HIV risk behaviors of Cuban-, Mexican-, and Puerto-Rican-born drug injectors who are recent entrants into the United States.

Authors:  R C Freeman; M L Williams; L A Saunders
Journal:  Subst Use Misuse       Date:  1999-11       Impact factor: 2.164

4.  Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco.

Authors:  A H Kral; J Lorvick; B R Edlin
Journal:  J Acquir Immune Defic Syndr       Date:  2000-06-01       Impact factor: 3.731

5.  Structural factors in HIV prevention: concepts, examples, and implications for research.

Authors:  E Sumartojo
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

6.  Migration and HIV risk behaviors: Puerto Rican drug injectors in New York City and Puerto Rico.

Authors:  Sherry Deren; Sung-Yeon Kang; Hector M Colón; Jonny F Andia; Rafaela R Robles; Denise Oliver-Velez; Ann Finlinson
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

7.  HIV risk reduction among African-American women who inject drugs: a randomized controlled trial.

Authors:  Claire E Sterk; Katherine P Theall; Kirk W Elifson; Daniel Kidder
Journal:  AIDS Behav       Date:  2003-03

8.  HIV prevention among drug users: outcome of a network-oriented peer outreach intervention.

Authors:  Carl A Latkin; Susan Sherman; Amy Knowlton
Journal:  Health Psychol       Date:  2003-07       Impact factor: 4.267

9.  Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

Authors:  R Andersen; S Bozzette; M Shapiro; P St Clair; S Morton; S Crystal; D Goldman; N Wenger; A Gifford; A Leibowitz; S Asch; S Berry; T Nakazono; K Heslin; W Cunningham
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

10.  "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Holly Hagan; Judith Milliken; Naomi Braine; Stanley Yancovitz; Donna Mildvan; David C Perlman; Carey Maslow; Samuel R Friedman
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

View more
  8 in total

1.  Factors associated with HIV stigma and the impact of a nonrandomized multi-component video aimed at reducing HIV stigma among a high-risk population in New York City.

Authors:  Alexis V Rivera; Jennifer DeCuir; Natalie D Crawford; Silvia Amesty; Katherine Harripersaud; Crystal F Lewis
Journal:  AIDS Care       Date:  2015-01-06

2.  Physical victimization and high-risk sexual partners among illicit drug-using heterosexual men in New York City.

Authors:  Alezandria K Turner; Kandice C Jones; Abby Rudolph; Alexis V Rivera; Natalie Crawford; Crystal Fuller Lewis
Journal:  J Urban Health       Date:  2014-10       Impact factor: 3.671

3.  Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis.

Authors:  Tina M Calderon; Dionna W Williams; Lillie Lopez; Eliseo A Eugenin; Laura Cheney; Peter J Gaskill; Mike Veenstra; Kathryn Anastos; Susan Morgello; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2017-01-29       Impact factor: 4.147

4.  Current and emerging research needs in studying the NYC HIV-drug use epidemic.

Authors:  Sherry Deren; Holly Hagan; Samuel Friedman; Don C Des Jarlais; David Perlman; Marya Gwadz; Charles Cleland; Andrew Osborne; Joseph Lunievicz
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

5.  Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks.

Authors:  Chyvette Williams; Marlene Eisenberg; Julie Becher; Annet Davis-Vogel; Danielle Fiore; David Metzger
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

6.  Individual and Neighborhood Characteristics Associated with HIV Among Black and Latino Adults Who Use Drugs and Unaware of Their HIV-Positive Status, New York City, 2000-2004.

Authors:  Crystal Fuller Lewis; Alexis V Rivera; Natalie D Crawford; Kirsha Gordon; Kellee White; David Vlahov; Sandro Galea
Journal:  J Racial Ethn Health Disparities       Date:  2015-12-10

7.  Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; David C Perlman; Susan Tross
Journal:  Drug Alcohol Depend       Date:  2019-08-30       Impact factor: 4.492

Review 8.  Preventing Unequal Health Outcomes in COVID-19: A Systematic Review of Past Interventions.

Authors:  Beth E Williams; Karli K Kondo; Chelsea K Ayers; Devan Kansagara; Sarah Young; Somnath Saha
Journal:  Health Equity       Date:  2021-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.